Benzinga's Top Upgrades, Downgrades For August 16, 2018

Top Upgrades

  • Argus upgraded Lululemon Athletica inc. LULU from Hold to Buy. Lululemon shares rose 1.02 percent to $127.74 in pre-market trading.
  • Morgan Stanley upgraded Embraer SA (ADR) ERJ from Equal-Weight to Overweight. Embraer shares fell 2.51 percent to close at $18.65 on Wednesday.
  • Analysts at Compass Point upgraded GreenSky Inc GSKY from Neutral to Buy. GreenSky shares fell 1.83 percent to $15.62 in pre-market trading.
  • Canaccord Genuity upgraded Canopy Growth Corp CGC from Hold to Speculative Buy. Canopy Growth shares rose 2.93 percent to $33.05 in pre-market trading.
  • Jefferies upgraded TechnipFMC PLC FTI from Hold to Buy. TechnipFMC shares rose 1.27 percent to $27.95 in pre-market trading.
  • Goldman Sachs upgraded Avalara Inc AVLR from Neutral to Buy. Avalara shares rose 6 percent to $36.75 in pre-market trading.
  • JP Morgan upgraded Kimberly Clark Corp KMB from Underweight to Neutral. Kimberly-Clark shares rose 0.46 percent to $116.99 in pre-market trading.

 

Top Downgrades

  • Macquarie downgraded Himax Technologies, Inc. (ADR) HIMX from Outperform to Neutral. Himax shares fell 8 percent to close at $5.98 on Wednesday.
  • Morgan Stanley downgraded Healthcare Trust Of America Inc HTA from Overweight to Equal-Weight. Healthcare Trust shares fell 0.48 percent to $28.82 in pre-market trading.
  • DA Davidson downgraded Nanometrics Incorporated NANO from Buy to Neutral. Nanometrics shares fell 2.39 percent to $44.14 in pre-market trading.
  • HSBC downgraded Cemex SAB de CV (ADR) ADR CX from Buy to Hold. Cemex shares fell 3.82 percent to close at $6.79 on Wednesday.
  • Canaccord Genuity downgraded Cenovus Energy Inc CVE from Buy to Hold. Cenovus Energy shares rose 1.67 percent to $9.10 in pre-market trading.
  • Jefferies downgraded AstraZeneca plc (ADR) AZN from Buy to Hold. AstraZeneca shares fell 0.34 percent to $38.32 in pre-market trading.
  • Barclays downgraded Grupo Aeroportuario del Centro Nort(ADR) OMAB from Overweight to Equal-Weight. Grupo Aeroportuario del Centro Nort(ADR) shares fell 3.04 percent to close at $49.40 on Wednesday.
  • KeyBanc downgraded Multi-Color Corporation LABL from Sector Weight to Underweight. Multi-Color shares fell 0.01 percent to $63.84 in pre-market trading.
  • Bank of America downgraded Coty Inc COTY from Buy to Underperform. Coty shares fell 2.19 percent to $11.18 in pre-market trading.

 

Top Initiations

  • UBS initiated Lockheed Martin Corporation LMT with a Buy rating. The price target for Lockheed Martin is set to $400. Lockheed Martin shares closed at $317.70 on Wednesday.
  • Leerink Swann initiated coverage on Teladoc Health Inc TDOC with an Outperform rating. The price target for Teladoc Health is set to $90. Teladoc Health shares closed at $70.75 on Wednesday.
  • Analysts at H.C. Wainwright initiated coverage on AVEO Pharmaceuticals, Inc. AVEO with a Buy rating. The price target for AVEO Pharmaceuticals is set to $6.50. AVEO Pharmaceuticals shares closed at $2.18 on Wednesday.
  • Analysts at UBS initiated coverage on Northrop Grumman Corporation NOC with a Neutral rating. The price target for Northrop Grumman is set to $315. Northrop Grumman shares closed at $291.51 on Wednesday.
  • Piper Jaffray initiated coverage on Post Holdings Inc POST with an Overweight rating. The price target for Post Holdings is set to $115. Post Holdings closed at $94.78 on Wednesday.
  • BTIG Research initiated coverage on Stryker Corporation SYK with a Buy rating. The price target for Stryker is set to $187. Stryker shares closed at $166.78 on Wednesday.
  • Jefferies initiated coverage on Conn's Inc CONN with a Buy rating. The price target for Conn's is set to $44. Conn's shares closed at $33.85 on Wednesday.
  • Analysts at Chardan Capital initiated coverage on eHealth, Inc. EHTH with a Buy rating. The price target for eHealth is set to $40. eHealth closed at $29.04 on Wednesday.
  • Ladenburg Thalmann initiated coverage on AcelRx Pharmaceuticals Inc ACRX with a Buy rating. The price target for AcelRx Pharmaceuticals is set to $7. AcelRx Pharmaceuticals shares closed at $2.95 on Wednesday.
  • Analysts at UBS initiated coverage on Hexcel Corporation HXL with a Sell rating. The price target for Hexcel is set to $65. Hexcel closed at $68.42 on Wednesday.
Posted In: Aerospace & DefenseApparel, Accessories & Luxury GoodsConsumer DiscretionaryIndustrialsInformation TechnologyInitiationsSemiconductor Equipmenttop upgradesUpgradesDowngradesInitiationPre-Market OutlookAnalyst Ratings